1 0 and its sensitivity to potential sequencing errors. We identified Ralstonia mannitolilytica as significantly increased in COPD patients 3 3 5
with frequent exacerbator phenotype. R. mannitolilytica is an opportunistic pathogen 3 3 6
that has been recovered from cystic fibrosis airways [36] . In a previous report, the 3 3 7 same species was isolated from one COPD exacerbation patient in western China 3 3 8
with extreme symptoms and acute respiratory failure [37] . Ralstonia spp. rarely cause 3 3 9
infection in healthy individuals but can be a severe pathogen especially in 3 4 0
immunosuppressed patients [38] . Therefore, the presence of R. mannitolilytica in 3 4 1 stable COPD patients may be an important contributing factor in predisposing patients 3 4 2
to recurrent infection and exacerbations. that sequencing V1V3 region may be a surrogate for the full-length 16S data.
4 8
Conversely, sequencing V4 alone, despite its wide usage in airway microbiome 3 4 9 studies, might not provide sufficient resolution for in-depth taxonomic profiling. With augmented power in functional inference, we identified butyrate-producing and 3 5 2 nitrate reduction pathways as uniquely depleted in COPD using full-length 16S data.
5 3
Butyrate is a well-characterized microbial metabolite with anti-inflammatory effects [39] , 3 5 4
and nitric oxide, the end product of nitrate reduction, may also have 3 5 5
disease-ameliorating role via suppressing NLRP3 inflammasome activation [40] .
5 6
Functional validations are warranted to explore these microbial metabolites as novel 3 5 7 therapies for COPD. The limitations of this study include its single-centered, cross-sectional design, the 3 6 0
relatively small group of healthy subjects, and the absence of sufficient data to explore 3 6 1 species-specific relationships with other etiological factors such as viral infections.
6 2
The species-level characterization on larger, longitudinal cohorts is necessary to In summary, we reported the comprehensive landscape of COPD airway microbiome 3 6 8
at species and strain-levels. We showed there was substantial intra-genus 1 1
Sequencing the full-length 16S rRNA gene enabled a refined, ecologically coherent 3 7 1 view on the composition and function of the COPD airway microbiome, and should 3 7 2 see a wider applicability in airway microbiome studies in future. Random Forest analyses using the 11 species-level and 9 genus-level discriminatory each species (Sp) and its corresponding genus (Gn) in COPD patients versus 3 9 1 controls were shown beside the taxonomy. between healthy controls and COPD patients with increasing disease severity based 3 9 6
on GOLD classification (spirometry-based). The number of subjects in each subgroup 3 9 7
was indicated in the parenthesis. clustered into four groups based on their association patterns with the three groups of 1 3 mediators (termed "Pro-inflammatory", "Neutrophilic", "Eosinophilic" and 4 1 7
"Anti-inflammatory"). The significant associations were indicated in asterisks. . . . W a n g Z , . (  2  )  :  3  3  6  -3  6  3  .  5  4  2   2  9  .  B  o  u  s  b  i  a  S  ,  P  a  p  a  z  i  a  n  L  ,  A  u  f  f  r  a  y  J  P  ,  F  e  n  o  l  l  a  r  F  ,  M  a  r  t  i  n  C  ,  L  i  W  ,  C  h  i  c  h  e  L  ,  L  a  S  c  o  l  a  B  ,  5  4 
